Yuro Haruta
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Glycosylation and Glycoproteins Research 7
- Protein purification and stability 2
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Ben K. Seon (14 shared papers)Fumihiko Matsuno (5 shared papers)Maurice Barcos (4 shared papers)Masao Kondo (2 shared papers)Hilda Tsai (5 shared papers)Akinao Haba (4 shared papers)Masao Kondô (1 shared paper)Masahiro Tabata (1 shared paper)
- Journals
- Biochemical Pharmacology (2 papers)International Journal of Cancer (2 papers)Cancer Research (2 papers)Biochemical and Biophysical Research Communications (1 paper)Current Drug Delivery (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Yuro Haruta
22 papers receiving 743 citations
Peers
Comparison fields: 5 of 61
- Immunology and Allergy 80
- Cancer Research 147
- Oncology 208
- Biotechnology 57
- Radiology, Nuclear Medicine and Imaging 135
Countries citing papers authored by Yuro Haruta
This map shows the geographic impact of Yuro Haruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuro Haruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuro Haruta more than expected).
Fields of papers citing papers by Yuro Haruta
This network shows the impact of papers produced by Yuro Haruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuro Haruta. The network helps show where Yuro Haruta may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuro Haruta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin. | 1997 | 137 |
| 2 | Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. | 1999 | 122 |
| 3 | 2010 | 112 | |
| 4 | Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. | 2001 | 102 |
| 5 | 1999 | 63 | |
| 6 | 1986 | 53 | |
| 7 | 2006 | 38 | |
| 8 | Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6. | 1988 | 24 |
| 9 | Production of a monoclonal antibody-methotrexate conjugate utilizing dextran T-40 and its biologic activity. | 1984 | 22 |
| 10 | 1983 | 20 | |
| 11 | 1985 | 15 | |
| 12 | Unique epitopes of common acute lymphoblastic leukemia antigen detected by new monoclonal antibodies. | 1987 | 11 |
| 13 | Establishment of ascitic tumor of human pre-B acute lymphoblastic leukemia in nonconditioned nude mice. | 1989 | 9 |
| 14 | Angiogenesis and metastasis marker of human tumors. | 2001 | 9 |
| 15 | 2014 | 7 | |
| 16 | New monoclonal antibodies SN3, SN3a, and SN3b directed to sialic acid of glycoprotein on human non-T leukemia cells. | 1986 | 7 |
| 17 | 1984 | 4 | |
| 18 | 1989 | 3 | |
| 19 | 2009 | 1 | |
| 20 | 2010 | 1 |
About Yuro Haruta
Yuro Haruta is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Oncology and Biotechnology, having authored 22 papers that have together received 762 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Angiogenesis and VEGF in Cancer (7 papers), Glycosylation and Glycoproteins Research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Cancer Cells and Metastasis (3 papers), Protein purification and stability (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Immunology and Allergy (80 citations), Cancer Research (147 citations), Oncology (208 citations), Biotechnology (57 citations) and Radiology, Nuclear Medicine and Imaging (135 citations). Yuro Haruta has collaborated with scholars based in United States and Japan. Frequent co-authors include Ben K. Seon, Fumihiko Matsuno, Maurice Barcos, Masao Kondo, Hilda Tsai, Akinao Haba, Masao Kondô, Masahiro Tabata, Henry J. Tsai and Masahiro Tabata. Their work appears in journals such as Biochemical Pharmacology, International Journal of Cancer, Cancer Research, Biochemical and Biophysical Research Communications and Current Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.